메뉴 건너뛰기




Volumn 1165, Issue , 2009, Pages 183-189

Effect of probiotics on intestinal barrier function

Author keywords

Bacterial translocation; Epithelial barrier; Inflammatory bowel disease; Intestinal barrier; Probiotics; Tight junction

Indexed keywords

BALSALAZIDE; MESALAZINE; PROBIOTIC AGENT;

EID: 67249106286     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04059.x     Document Type: Review
Times cited : (116)

References (64)
  • 1
    • 2142813761 scopus 로고    scopus 로고
    • A porous defense: The leaky epithelial barrier in intestinal disease
    • Clayburgh, D.R., L. Shen & J.R. Turner. 2004. A porous defense: the leaky epithelial barrier in intestinal disease. Lab. Invest. 84: 282-291.
    • (2004) Lab. Invest , vol.84 , pp. 282-291
    • Clayburgh, D.R.1    Shen, L.2    Turner, J.R.3
  • 2
    • 40049097843 scopus 로고    scopus 로고
    • Role of the intestinal barrier in inflammatory disease
    • Laukoetter, M.G., P. Nava & A. Nusrat. 2008. Role of the intestinal barrier in inflammatory disease. World J. Gastroenterol. 14: 401-407.
    • (2008) World J. Gastroenterol , vol.14 , pp. 401-407
    • Laukoetter, M.G.1    Nava, P.2    Nusrat, A.3
  • 4
    • 0031781603 scopus 로고    scopus 로고
    • Inflammatory bowel disease: Etiology and pathogenesis
    • Fiocchi, C. 1998. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182-205.
    • (1998) Gastroenterology , vol.115 , pp. 182-205
    • Fiocchi, C.1
  • 5
    • 0037043658 scopus 로고    scopus 로고
    • Inflammatory bowel disease
    • Podolsky, D.K. 2002. Inflammatory bowel disease. N. Engl. J. Med. 347: 417-429.
    • (2002) N. Engl. J. Med , vol.347 , pp. 417-429
    • Podolsky, D.K.1
  • 6
    • 0025314386 scopus 로고
    • Cellular basis for defective electrolyte transport in inflamed human colon
    • Sandle, G.I., N. Higgs, P. Crowe, et al. 1990. Cellular basis for defective electrolyte transport in inflamed human colon. Gastroenterology 99: 97-105.
    • (1990) Gastroenterology , vol.99 , pp. 97-105
    • Sandle, G.I.1    Higgs, N.2    Crowe, P.3
  • 7
    • 0032958705 scopus 로고    scopus 로고
    • Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis
    • Schmitz, H., C. Barmeyer, M. Fromm, et al. 1999. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 116: 301-309.
    • (1999) Gastroenterology , vol.116 , pp. 301-309
    • Schmitz, H.1    Barmeyer, C.2    Fromm, M.3
  • 9
    • 0035185891 scopus 로고    scopus 로고
    • Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins
    • Kucharzik, T., S.V. Walsh, J. Chen, et al. 2001. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am. J. Pathol. 159: 2001-2009.
    • (2001) Am. J. Pathol , vol.159 , pp. 2001-2009
    • Kucharzik, T.1    Walsh, S.V.2    Chen, J.3
  • 10
    • 4344700784 scopus 로고    scopus 로고
    • Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment
    • Zeissig, S., C. Bojarski, N. Buergel, et al. 2004. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment. Gut 53: 1295-1302.
    • (2004) Gut , vol.53 , pp. 1295-1302
    • Zeissig, S.1    Bojarski, C.2    Buergel, N.3
  • 11
    • 33845995125 scopus 로고    scopus 로고
    • Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease
    • Zeissig, S., N. Buergel, D. Guenzel, et al. 2007. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56: 61-72.
    • (2007) Gut , vol.56 , pp. 61-72
    • Zeissig, S.1    Buergel, N.2    Guenzel, D.3
  • 12
    • 84985161098 scopus 로고
    • Probiotics in man and animals
    • Fuller, R. 1989. Probiotics in man and animals. J. Appl. Bacteriol. 66: 365-378.
    • (1989) J. Appl. Bacteriol , vol.66 , pp. 365-378
    • Fuller, R.1
  • 13
    • 0031443860 scopus 로고    scopus 로고
    • Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?
    • Malchow, H.A. 1997. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? J. Clin. Gastroenterol. 25: 653-658.
    • (1997) J. Clin. Gastroenterol , vol.25 , pp. 653-658
    • Malchow, H.A.1
  • 14
    • 0032815979 scopus 로고    scopus 로고
    • Impact on the composition of the faecal flora by a new probiotic preparation: Preliminary data on maintenance treatment of patients with ulcerative colitis
    • Venturi, A., P. Gionchetti, F. Rizzello, et al. 1999. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment. Pharmacol. Ther. 13: 1103-1108.
    • (1999) Aliment. Pharmacol. Ther , vol.13 , pp. 1103-1108
    • Venturi, A.1    Gionchetti, P.2    Rizzello, F.3
  • 15
    • 0033860601 scopus 로고    scopus 로고
    • Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
    • Gionchetti, P., F. Rizzello, A. Venturi, et al. 2000. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119: 305-309.
    • (2000) Gastroenterology , vol.119 , pp. 305-309
    • Gionchetti, P.1    Rizzello, F.2    Venturi, A.3
  • 16
    • 0038185270 scopus 로고    scopus 로고
    • Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial
    • Gionchetti, P., F. Rizzello, U. Helwig, et al. 2003. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124: 1202-1209.
    • (2003) Gastroenterology , vol.124 , pp. 1202-1209
    • Gionchetti, P.1    Rizzello, F.2    Helwig, U.3
  • 17
    • 9144254035 scopus 로고    scopus 로고
    • Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis
    • Mimura, T., F. Rizzello, U. Helwig, et al. 2004. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53: 108-114.
    • (2004) Gut , vol.53 , pp. 108-114
    • Mimura, T.1    Rizzello, F.2    Helwig, U.3
  • 18
    • 37249053411 scopus 로고    scopus 로고
    • High-dose probiotics for the treatment of active pouchitis
    • Gionchetti, P., F. Rizzello, C. Morselli, et al. 2007. High-dose probiotics for the treatment of active pouchitis. Dis. Colon Rectum 50: 2075-2082.
    • (2007) Dis. Colon Rectum , vol.50 , pp. 2075-2082
    • Gionchetti, P.1    Rizzello, F.2    Morselli, C.3
  • 19
    • 0038460949 scopus 로고    scopus 로고
    • Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC)
    • Resta-Lenert, S. & K.E. Barrett. 2003. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52: 988-997.
    • (2003) Gut , vol.52 , pp. 988-997
    • Resta-Lenert, S.1    Barrett, K.E.2
  • 20
    • 0345447585 scopus 로고    scopus 로고
    • Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms
    • Bruewer, M., A. Luegering, T. Kucharzik, et al. 2003. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J. Immunol. 171: 6164-6172.
    • (2003) J. Immunol , vol.171 , pp. 6164-6172
    • Bruewer, M.1    Luegering, A.2    Kucharzik, T.3
  • 21
    • 4344653745 scopus 로고    scopus 로고
    • Lactobacillus acidophilus protects tight junctions from aspirin damage in HT-29 cells
    • Montalto, M., N. Maggiano, R. Ricci, et al. 2004. Lactobacillus acidophilus protects tight junctions from aspirin damage in HT-29 cells. Digestion 69: 225-228.
    • (2004) Digestion , vol.69 , pp. 225-228
    • Montalto, M.1    Maggiano, N.2    Ricci, R.3
  • 22
    • 20444481707 scopus 로고    scopus 로고
    • Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process
    • Bruewer, M., M. Utech, A.I. Ivanov, et al. 2005. Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J. 19: 923-933.
    • (2005) FASEB J , vol.19 , pp. 923-933
    • Bruewer, M.1    Utech, M.2    Ivanov, A.I.3
  • 23
    • 14644431007 scopus 로고    scopus 로고
    • Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Es-cherichia coli-infected T84 cells
    • Parassol, N., M. Freitas, K. Thoreux, et al. 2005. Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Es-cherichia coli-infected T84 cells. Res. Microbiol. 156: 256-262.
    • (2005) Res. Microbiol , vol.156 , pp. 256-262
    • Parassol, N.1    Freitas, M.2    Thoreux, K.3
  • 24
    • 33846894974 scopus 로고    scopus 로고
    • Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair
    • Zyrek, A.A., C. Cichon, S. Helms, et al. 2007. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol. 9: 804-816.
    • (2007) Cell Microbiol , vol.9 , pp. 804-816
    • Zyrek, A.A.1    Cichon, C.2    Helms, S.3
  • 25
    • 0037185020 scopus 로고    scopus 로고
    • Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells
    • Yan, F. & D.B. Polk. 2002. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J. Biol. Chem. 277: 50959-50965.
    • (2002) J. Biol. Chem , vol.277 , pp. 50959-50965
    • Yan, F.1    Polk, D.B.2
  • 26
    • 33846175058 scopus 로고    scopus 로고
    • The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells
    • Caballero-Franco, C., K. Keller, C. De Simone, et al. 2007. The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G315-G322.
    • (2007) Am. J. Physiol. Gastrointest. Liver Physiol , vol.292
    • Caballero-Franco, C.1    Keller, K.2    De Simone, C.3
  • 27
    • 0028202974 scopus 로고
    • Lactobacillus acidophilus LA1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria
    • Bernet, M.F., D. Brassart, J.R. Neeser, et al. 1994. Lactobacillus acidophilus LA1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 35: 483-489.
    • (1994) Gut , vol.35 , pp. 483-489
    • Bernet, M.F.1    Brassart, D.2    Neeser, J.R.3
  • 28
    • 38549171792 scopus 로고    scopus 로고
    • Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2
    • Schlee, M., J. Harder, B. Köten, et al. 2008. Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin. Exp. Immunol. 151: 528-535.
    • (2008) Clin. Exp. Immunol , vol.151 , pp. 528-535
    • Schlee, M.1    Harder, J.2    Köten, B.3
  • 29
    • 0034831139 scopus 로고    scopus 로고
    • Probiotic bacteria enhance murine and human intestinal epithelial barrier function
    • Madsen, K., A. Cornish, P. Soper, et al. 2001. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121: 580-591.
    • (2001) Gastroenterology , vol.121 , pp. 580-591
    • Madsen, K.1    Cornish, A.2    Soper, P.3
  • 30
    • 18944395895 scopus 로고    scopus 로고
    • Effect of lactobacillus on the gut microflora and barrier function of the rats with abdominal infection
    • Qin, H.L., T.Y. Shen, Z.G. Gao, et al. 2005. Effect of lactobacillus on the gut microflora and barrier function of the rats with abdominal infection. World J. Gastroenterol. 11: 2591-2596.
    • (2005) World J. Gastroenterol , vol.11 , pp. 2591-2596
    • Qin, H.L.1    Shen, T.Y.2    Gao, Z.G.3
  • 31
    • 34548757869 scopus 로고    scopus 로고
    • Prbiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis
    • Ewaschuk, J., R. Endersby, D. Thiel, et al. 2007. Prbiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology 46: 841-850.
    • (2007) Hepatology , vol.46 , pp. 841-850
    • Ewaschuk, J.1    Endersby, R.2    Thiel, D.3
  • 32
    • 33750364231 scopus 로고    scopus 로고
    • Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress
    • Zareie, M., K. Johnson-Henry, J. Jury, et al. 2006. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 55: 1553-1560.
    • (2006) Gut , vol.55 , pp. 1553-1560
    • Zareie, M.1    Johnson-Henry, K.2    Jury, J.3
  • 33
    • 34548107027 scopus 로고    scopus 로고
    • Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats
    • Eutamene, H., F. Lamine, C. Chabo, et al. 2007. Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats. J. Nutr. 137: 1901-1907.
    • (2007) J. Nutr , vol.137 , pp. 1901-1907
    • Eutamene, H.1    Lamine, F.2    Chabo, C.3
  • 34
    • 12144289109 scopus 로고    scopus 로고
    • Probiotics partly reverse increased bacterial translocation after simultaneous liver resection and colonic anastomosis in rats
    • Seehofer, D, N. Rayes, R.A. Schiller, et al. 2004. Probiotics partly reverse increased bacterial translocation after simultaneous liver resection and colonic anastomosis in rats. J. Surg. Res. 117: 262-271.
    • (2004) J. Surg. Res , vol.117 , pp. 262-271
    • Seehofer, D.1    Rayes, N.2    Schiller, R.A.3
  • 35
    • 1642322304 scopus 로고    scopus 로고
    • Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium
    • Osman, N., D. Adawi, S. Ahrne, et al. 2004. Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium. Dig. Dis. Sci. 49: 320-327.
    • (2004) Dig. Dis. Sci , vol.49 , pp. 320-327
    • Osman, N.1    Adawi, D.2    Ahrne, S.3
  • 36
    • 33947304497 scopus 로고    scopus 로고
    • Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis
    • van Minnen, L.P., H.M. Timmermann, F. Lutgendorff, et al. 2007. Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis. Surgery 141: 470-480.
    • (2007) Surgery , vol.141 , pp. 470-480
    • van Minnen, L.P.1    Timmermann, H.M.2    Lutgendorff, F.3
  • 37
    • 34247235029 scopus 로고    scopus 로고
    • Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function
    • Cario, E., G. Gerken & D.K. Podolsky. 2007. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132: 1359-1374.
    • (2007) Gastroenterology , vol.132 , pp. 1359-1374
    • Cario, E.1    Gerken, G.2    Podolsky, D.K.3
  • 38
    • 34247598857 scopus 로고    scopus 로고
    • Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis
    • Poritz, L.S., K.I. Garver, C. Green, et al. 2007. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis. J. Surg . Res. 140: 12-19.
    • (2007) J. Surg . Res , vol.140 , pp. 12-19
    • Poritz, L.S.1    Garver, K.I.2    Green, C.3
  • 39
    • 44949153787 scopus 로고    scopus 로고
    • Probiotic Escherichia coliNissle 1917 inhibits leaky gut by enhancing mucosal integrity
    • Ukena, S.N., A. Singh, U. Dringenberg, et al. 2007. Probiotic Escherichia coliNissle 1917 inhibits leaky gut by enhancing mucosal integrity. PloS ONE 2: e1308.
    • (2007) PloS ONE , vol.2
    • Ukena, S.N.1    Singh, A.2    Dringenberg, U.3
  • 40
    • 34249099761 scopus 로고    scopus 로고
    • The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis
    • Ramakers, J.D., M.I. Verstege, G. Thuijls, et al. 2007. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis. J. Clin. Immunol. 27: 275-283.
    • (2007) J. Clin. Immunol , vol.27 , pp. 275-283
    • Ramakers, J.D.1    Verstege, M.I.2    Thuijls, G.3
  • 41
    • 33747384568 scopus 로고    scopus 로고
    • VSL#3 probiotic mixture. A review of its use in chronic inflammatory bowel diseases
    • Chapman, T.M., G.L. Plosker & D.P. Figgitt. 2006. VSL#3 probiotic mixture. A review of its use in chronic inflammatory bowel diseases. Drugs 66: 1371-1387.
    • (2006) Drugs , vol.66 , pp. 1371-1387
    • Chapman, T.M.1    Plosker, G.L.2    Figgitt, D.P.3
  • 42
    • 33745599630 scopus 로고    scopus 로고
    • Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways
    • Grabig, A., D. Paclik, C. Guzy, et al. 2006. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. Infect. Immun. 74: 4075-4082.
    • (2006) Infect. Immun , vol.74 , pp. 4075-4082
    • Grabig, A.1    Paclik, D.2    Guzy, C.3
  • 43
    • 33745413808 scopus 로고    scopus 로고
    • Probiotics and inflammatory bowel diseases
    • Bai, A.P. & Q. Ouyang. 2006. Probiotics and inflammatory bowel diseases. Postgrad. Med. J. 82: 376-382.
    • (2006) Postgrad. Med. J , vol.82 , pp. 376-382
    • Bai, A.P.1    Ouyang, Q.2
  • 44
    • 10744233159 scopus 로고    scopus 로고
    • Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis
    • Rachmilewitz, D., K. Katakura, F. Karmeli, et al. 2004. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126: 520-528.
    • (2004) Gastroenterology , vol.126 , pp. 520-528
    • Rachmilewitz, D.1    Katakura, K.2    Karmeli, F.3
  • 45
    • 0033819854 scopus 로고    scopus 로고
    • Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study
    • Gupta, P., H. Andrew, B.S. Kirschner, et al. 2000. Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J. Pediatr. Gastroenterol. Nutr. 31: 453-457.
    • (2000) J. Pediatr. Gastroenterol. Nutr , vol.31 , pp. 453-457
    • Gupta, P.1    Andrew, H.2    Kirschner, B.S.3
  • 46
    • 46349091181 scopus 로고    scopus 로고
    • Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission
    • Garcia Vilela, E., M. de Lourdes de Abreu Ferrari, H. Oswaldo da Gama Torres, et al. 2008. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission. Scand. J. Gastroenterol. 43: 842-848.
    • (2008) Scand. J. Gastroenterol , vol.43 , pp. 842-848
    • Garcia Vilela, E.1    de Lourdes de Abreu Ferrari, M.2    Oswaldo da Gama Torres, H.3
  • 47
    • 0033870413 scopus 로고    scopus 로고
    • Saccharomyces boulardii in maintenance treatment of Crohn's disease
    • Guslandi, M., G. Mezzi, M. Sorghi, et al. 2000. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig. Dis. Sci. 45: 1462-1464.
    • (2000) Dig. Dis. Sci , vol.45 , pp. 1462-1464
    • Guslandi, M.1    Mezzi, G.2    Sorghi, M.3
  • 48
    • 0036716855 scopus 로고    scopus 로고
    • Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: A randomised controlled trial with Lactobacillus GG
    • Prantera, C., M.L. Scribano, G. Falasco, et al. 2002. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 51: 405-409.
    • (2002) Gut , vol.51 , pp. 405-409
    • Prantera, C.1    Scribano, M.L.2    Falasco, G.3
  • 49
    • 2442717706 scopus 로고    scopus 로고
    • Lactobacillus GG in inducing and maintaining remission of Crohn's disease
    • Schultz, M., A. Timmer, H.H. Herfarth, et al. 2004. Lactobacillus GG in inducing and maintaining remission of Crohn's disease. BMC Gastroenterol. 4: 5.
    • (2004) BMC Gastroenterol , vol.4 , pp. 5
    • Schultz, M.1    Timmer, A.2    Herfarth, H.H.3
  • 50
    • 22744438084 scopus 로고    scopus 로고
    • VSL#3 probiotic mixture induces remission in patients with active ulcerative colitis
    • Bibiloni, R., R.N. Fedorak, G.W. Tannock, et al. 2005. VSL#3 probiotic mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 100: 1539-1546.
    • (2005) Am. J. Gastroenterol , vol.100 , pp. 1539-1546
    • Bibiloni, R.1    Fedorak, R.N.2    Tannock, G.W.3
  • 51
    • 9144236376 scopus 로고    scopus 로고
    • Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis
    • Tursi, A., G. Brandimarte, G.M. Giorgetti, et al. 2004. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Med. Sci. Monit. 20: PI126-131.
    • (2004) Med. Sci. Monit , vol.20
    • Tursi, A.1    Brandimarte, G.2    Giorgetti, G.M.3
  • 52
    • 2342580955 scopus 로고    scopus 로고
    • Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis
    • Liu, Q., Z.P. Duan, D.K. Ha, et al. 2004. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 39: 1441-1449.
    • (2004) Hepatology , vol.39 , pp. 1441-1449
    • Liu, Q.1    Duan, Z.P.2    Ha, D.K.3
  • 53
    • 52149114013 scopus 로고    scopus 로고
    • Clinical trial: Effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhea-predominant irritable bowel syndrome
    • Zeng, J., Y.Q. Li, X.L. Zuo, et al. 2008. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 28: 994-1002.
    • (2008) Aliment. Pharmacol. Ther , vol.28 , pp. 994-1002
    • Zeng, J.1    Li, Y.Q.2    Zuo, X.L.3
  • 54
    • 37549004433 scopus 로고    scopus 로고
    • Intestinal permeability and effects of Lactobacillus rhamnosus therapy in children with short bowel syndrome
    • Sentongo, T.A., V. Cohran, S. Korff, et al. 2008. Intestinal permeability and effects of Lactobacillus rhamnosus therapy in children with short bowel syndrome. J. Pediatr. Gastroenterol. Nutr. 46: 41-47.
    • (2008) J. Pediatr. Gastroenterol. Nutr , vol.46 , pp. 41-47
    • Sentongo, T.A.1    Cohran, V.2    Korff, S.3
  • 55
    • 11844284850 scopus 로고    scopus 로고
    • Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - a randomized, double-blind trial
    • Rayes, N., D. Seehofer, T. Theruvath, et al. 2005. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - a randomized, double-blind trial. Am. J. Transplant. 5: 125-130.
    • (2005) Am. J. Transplant , vol.5 , pp. 125-130
    • Rayes, N.1    Seehofer, D.2    Theruvath, T.3
  • 56
    • 34347330287 scopus 로고    scopus 로고
    • Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancre-atoduodenectomy. A randomized, double-blind trial
    • Rayes, N., D. Seehofer, T. Theruvath, et al. 2007. Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancre-atoduodenectomy. A randomized, double-blind trial. Ann. Surg. 246: 36-41.
    • (2007) Ann. Surg , vol.246 , pp. 36-41
    • Rayes, N.1    Seehofer, D.2    Theruvath, T.3
  • 57
    • 34248361622 scopus 로고    scopus 로고
    • Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy
    • Reddy, B.S., J. Macfie, M. Gatt, et al. 2007. Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy. Br. J. Surg. 94: 546-554.
    • (2007) Br. J. Surg , vol.94 , pp. 546-554
    • Reddy, B.S.1    Macfie, J.2    Gatt, M.3
  • 58
    • 0036895047 scopus 로고    scopus 로고
    • A prospective randomised study of the probiotic Lactobacillus plantarum 299v on indices of gut barrier function in elective surgical patients
    • McNaught, C.E., N.P. Woodcock, J. MacFie, et al. 2002. A prospective randomised study of the probiotic Lactobacillus plantarum 299v on indices of gut barrier function in elective surgical patients. Gut 51: 827-831.
    • (2002) Gut , vol.51 , pp. 827-831
    • McNaught, C.E.1    Woodcock, N.P.2    MacFie, J.3
  • 59
    • 2942538737 scopus 로고    scopus 로고
    • Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: A randomised controlled trial
    • Jain, P.K., C.E. McNaught, A.D. Anderson, et al. 2004. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clin. Nutr. 23: 467-475.
    • (2004) Clin. Nutr , vol.23 , pp. 467-475
    • Jain, P.K.1    McNaught, C.E.2    Anderson, A.D.3
  • 60
    • 0036360638 scopus 로고    scopus 로고
    • Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis
    • Olah, A., T. Belagyi, A. Issekutz, et al. 2002. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br. J. Surg. 89: 1103-1107.
    • (2002) Br. J. Surg , vol.89 , pp. 1103-1107
    • Olah, A.1    Belagyi, T.2    Issekutz, A.3
  • 61
    • 34248157583 scopus 로고    scopus 로고
    • Synbiotic control of inflammation and infection in severe acute pancreatitis: A prospective, randomized, double blind study
    • Olah, A., T. Belagyi, L. Poto, et al. 2007. Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double blind study. Hepatogastroenterology 54: 590-594.
    • (2007) Hepatogastroenterology , vol.54 , pp. 590-594
    • Olah, A.1    Belagyi, T.2    Poto, L.3
  • 62
    • 34548672553 scopus 로고    scopus 로고
    • Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: A randomized placebo-controlled trial
    • Honeycutt, T.C., M. El Khashab, R.M. Wardrop, et al. 2007. Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial. Pediatr. Crit. Care Med. 8: 452-458.
    • (2007) Pediatr. Crit. Care Med , vol.8 , pp. 452-458
    • Honeycutt, T.C.1    El Khashab, M.2    Wardrop, R.M.3
  • 63
    • 39449089584 scopus 로고    scopus 로고
    • Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial
    • Besselink, M.G.H., H.C. van Santvoort, E. Buskens, et al. 2008. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371: 651-659.
    • (2008) Lancet , vol.371 , pp. 651-659
    • Besselink, M.G.H.1    van Santvoort, H.C.2    Buskens, E.3
  • 64
    • 66149090738 scopus 로고    scopus 로고
    • Mennigen, R., K. Nolte, E.M. Rijcken, et al. 2009. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. [Epub ahead of print].
    • Mennigen, R., K. Nolte, E.M. Rijcken, et al. 2009. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. [Epub ahead of print].


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.